Kiora Share Price

Kiora Share Price

NASDAQ: KPRX | Micro Cap | Healthcare
$0.72
+$0.72 (--%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Kiora Stock Performance

Open
$0.78
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.75 - $0.78
Year Range
$0.75 - $2.89
Volume
1,492
Average Traded
$0.75

Kiora Share Price Chart

Line chart of the Kiora price trend over the selected period. The price rose overall, ranging from 0.72 to 0.78, ending at 0.72.
$0.75$0.78
L
Show Current Price
H

Kiora Stock Fundamentals & Key Indicators

Market Cap
$3.00M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.88
Revenue (TTM)
$0.00
Return On Equity (TTM)
-83.44%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
73.16%

Kiora Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$1.00
Net Profit-$6.52-$2.42-$2.08-$1.75
Net Profit MarginN/AN/AN/A-175.00%
Income ChangeN/A62.88%14.05%15.87%

Kiora Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$16.02$0.00
Net Profit-$13.58-$13.04$3.59-$10.84
Net Profit MarginN/AN/A22.41%N/A
Income ChangeN/A3.98%127.53%-401.95%

Kiora Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets2.56.788.9711.0
Current Assets21.7529.714.747.68
Total Assets24.2536.4813.7118.68
Non Current Liabilities4.54.725.974.0
Current Liabilities3.636.011.633.27
Total Liabilities8.1310.727.67.27
Shareholders' Equity16.1325.766.1111.41

Kiora Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-9.968.56-9.56-10.43
Investing14.43-22.660.00.01
Financing0.2715.55.978.62

Corporate Actions

Split
Ex-date: 11 Jun 2024

Split
Ex-date: 27 Sep 2022

Split
Ex-date: 30 Aug 2019

About Kiora

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Kiora Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.79
$0.75
-53.13%
Oct 2026
$2.55
$1.60
-41.18%
Sep 2026
$2.54
$2.72
+3.82%
Aug 2026
$2.61
$2.62
+5.22%
Jul 2026
$2.67
$2.49
-4.41%
Jun 2026
$2.71
$2.60
-4.58%
May 2026
$2.40
$2.73
+15.68%
Apr 2026
$1.90
$2.36
+24.87%
Mar 2026
$2.02
$1.89
-7.35%
Feb 2026
$2.40
$2.04
-14.47%
Jan 2026
$1.99
$2.38
+22.31%
Dec 2025
$1.92
$1.95
+2.63%

Kiora Share Price FAQs